CHR
Cheer Holding, Inc.
There isn't enough reported data to score CHR yet.
VZ
Verizon Communications Inc.
VZ's fundamentals are mixed: it turned 28% of its revenue into free cash flow, but its operating margin fell 2 points to 21%. At 12x earnings, it's trading in line with its usual 11x. Analysts expect earnings growth.
CHR Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Healthy | |
| Stable | |
| Healthy |
CHR's profitability and balance sheet are currently healthy, and its cash flow is stable, but its revenue is under pressure.
VZ Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Under pressure |
VZ's profitability and cash flow are currently healthy, and its revenue is stable, but its balance sheet is under pressure.
CHR PE Valuation
CHR has no meaningful PE right now: it lost money over the past year.
VZ PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.3x | $32.43 | -30% |
| Forward | 9x | $46.55 | — |
| Fair | 11x | $43.63 | -6.3% |
| Current | 12x | $46.55 | — |
| Expensive | 14x | $56.75 | +22% |
Historical ranges are pointers, not guarantees.
VZ's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 9.0x next year's earnings, in its cheap range.
CHR Forward outlook
There aren't enough analyst estimates for CHR to show an outlook.
VZ Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect VZ's earnings to grow and its profitability to improve, with its revenue holding steady.
CHR Earnings Per Share
CHR and VZ do not have enough comparable growth data to identify a winner.
VZ Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.19 | +32% |
| Q3 2026 | $3.93 | -16% |
| Q2 2026 | $3.85 | -10% |
| Q1 2026 | $4.11 | -2.1% |
| Q4 2025 | $4.06 | -1.9% |
| Q3 2025 | $4.68 | +103% |
| Q2 2025 | $4.29 | +61% |
| Q1 2025 | $4.20 | +57% |
| Q4 2024 | $4.14 | +51% |
VZ's earnings per share have fallen from their peak: $3.93 over the past year, against $5.34 in late 2021.
CHR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $30.3M | -15% |
| Q1 2026 | $30.3M | -15% |
| Q4 2025 | $38.9M | +2.2% |
| Q3 2025 | $38.9M | +2.2% |
| Q2 2025 | $35.5M | -50% |
| Q4 2024 | $38.1M | -55% |
| Q2 2024 | $71.1M | +5.4% |
| Q4 2023 | $84.9M | -2.6% |
CHR's revenue has slid since its 2022 peak: $30M last quarter, down 15% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 17% | +5.6 points |
| Q1 2026 | 17% | +5.6 points |
| Q4 2025 | 23% | +4.8 points |
| Q3 2025 | 23% | +4.8 points |
| Q2 2025 | 12% | -4.6 points |
| Q1 2025 | 12% | N/A |
| Q4 2024 | 18% | -5.9 points |
| Q3 2024 | 18% | N/A |
CHR's operating margin was 17% last quarter, up 5.6 points from the same quarter a year ago.
VZ Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $34.3B | +1.5% |
| Q2 2026 | $34.3B | -0.7% |
| Q1 2026 | $34.4B | +2.9% |
| Q4 2025 | $36.4B | +2% |
| Q3 2025 | $33.8B | +1.5% |
| Q2 2025 | $34.5B | +5.2% |
| Q1 2025 | $33.5B | +1.5% |
| Q4 2024 | $35.7B | +1.6% |
VZ has the edge over CHR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 25% | +1.3 points |
| Q2 2026 | 21% | -2.7 points |
| Q1 2026 | 24% | +0.1 points |
| Q4 2025 | 14% | -7.1 points |
| Q3 2025 | 24% | +6.2 points |
| Q2 2025 | 24% | -0.2 points |
| Q1 2025 | 24% | +1 points |
| Q4 2024 | 21% | +19 points |
VZ has the edge over CHR on profitability, with a higher operating margin.
CHR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$15.1M | -871% |
| Q1 2026 | $17.9M | +815% |
| Q4 2025 | $7M | -53% |
| Q3 2025 | $7M | -53% |
| Q2 2025 | $2M | +$8.7M |
| Q1 2025 | $2M | +$5.3M |
| Q4 2024 | $14.8M | -1.3% |
| Q3 2024 | $14.8M | +97% |
CHR usually generates cash, though not every quarter: the latest was −$15M, but it generated $17M over the past year.
VZ Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $11.5B | +2.2% |
| Q2 2026 | $10.4B | +16% |
| Q1 2026 | $8B | +2.6% |
| Q4 2025 | $9.1B | -13% |
| Q3 2025 | $11.3B | +14% |
| Q2 2025 | $9B | -5.4% |
| Q1 2025 | $7.8B | +9.9% |
| Q4 2024 | $10.4B | +20% |
VZ has the edge over CHR on cash flow, with more consistent year-over-year improvement.
CHR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | -62% | -124K shares |
| 3 years | +1564% | +72.6K shares |
CHR has the edge over VZ on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
VZ Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -10M shares |
| 1 year | -1.7% | -72M shares |
| 3 years | -1.3% | -55M shares |
| 5 years | +0.4% | +17M shares |
| Available history | +0.5% | +21M shares |
VZ has 4.2B diluted shares, down 1.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $500M |
| Q2 2026 | $1B |
| Q1 2026 | $2.5B |
CHR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -4.8x | Net Cash |
| Q1 2026 | -5.0x | Net Cash |
| Q4 2025 | -6.7x | Net Cash |
| Q3 2025 | -7.6x | Net Cash |
| Q2 2025 | -7.5x | Net Cash |
| Q1 2025 | -5.7x | Net Cash |
CHR has the edge over VZ on leverage, with a lower net debt burden relative to earnings.
VZ Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.3x | Elevated |
| Q2 2026 | 3.4x | Elevated |
| Q1 2026 | 3.4x | Elevated |
| Q4 2025 | 2.9x | Moderate |
| Q3 2025 | 2.8x | Moderate |
| Q2 2025 | 3.0x | Moderate |
| Q1 2025 | 3.0x | Elevated |
| Q4 2024 | 3.0x | Elevated |
VZ's net debt is about 3.3 years of its operating earnings (EBITDA), up from 2.8 years a year ago.
CHR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 25.6 | Oversold |
| Stochastic | 15.4 | Oversold |
CHR's weekly RSI is 26 (oversold) and its Stochastic is 15 (oversold).
VZ Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.9 | Neutral |
| Stochastic | 44.6 | Neutral |
VZ's weekly RSI is 51 (neutral) and its Stochastic is 45 (neutral).
CHR PE vs Communication Services Sector
CHR has no meaningful PE right now: it lost money over the past year.
VZ PE vs Communication Services Sector
| Metric | VZ | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 16x | 28% below |
| PE % | 58 | 26 | 32 pts above |
VZ is trading at 12x earnings, a 28% discount to the Communication Services sector's median of 16x.
CHR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.43 | 7.7% below |
| 20 week MA | $1.67 | 21% below |
| 50 week MA | $2.59 | 49% below |
| 100 week MA | $103.9 | 99% below |
| 200 week MA | $363.1 | 100% below |
CHR is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
VZ Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $45.1 | 3.1% above |
| 20 week MA | $46.3 | 0.5% above |
| 50 week MA | $46.1 | 1.1% above |
| 100 week MA | $44.2 | 5.4% above |
| 200 week MA | $41.4 | 12% above |
VZ has the edge over CHR on trend strength, trading above more of its moving averages.
CHR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $15,450.0 | $3,945.0 | -74% |
| 2021 | $3,945.0 | $1,935.0 | -51% |
| 2022 | $1,935.0 | $2,220.0 | +15% |
| 2023 | $2,220.0 | $471.0 | -79% |
| 2024 | $471.0 | $387.0 | -18% |
| 2025 | $387.0 | $4.38 | -99% |
| 2026 YTD | $4.38 | $1.32 | -70% |
CHR has finished three years in a row lower, and it's down 70% so far in 2026.
VZ Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $61.5 | $58.8 | -4.4% |
| 2021 | $58.8 | $52.7 | -10% |
| 2022 | $52.7 | $38.4 | -27% |
| 2023 | $38.4 | $37.7 | -1.8% |
| 2024 | $37.7 | $39.9 | +5.9% |
| 2025 | $39.9 | $40.5 | +1.4% |
| 2026 YTD | $40.5 | $46.6 | +15% |
VZ has the edge over CHR on returns for 2026, with the stronger performance.